However, the Boston study showed this progressive, tau proteinarray in football players much too young for a dementia diagnosis, which typically occurs in people in their 70s or 80s.
Those drugs aim to improve on current treatment regimens based on the immune protein alpha interferon--which often don't work and have an array of nasty side effects.